Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer

NCT00553696 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: Cisplatin
DRUG: S-1
DRUG: Sunitinib

Sponsor

Pfizer